Effects of Salpingectomy During Laparoscopic Hysterectomy on Ovarian Function
|ClinicalTrials.gov Identifier: NCT01578759|
Recruitment Status : Completed
First Posted : April 17, 2012
Last Update Posted : April 25, 2017
|Condition or disease||Intervention/treatment|
|Laparoscopic Hysterectomy||Procedure: Salpingectomy|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Effects of Salpingectomy During Laparoscopic Hysterectomy on Ovarian Function|
|Study Start Date :||April 2012|
|Primary Completion Date :||October 2013|
|Study Completion Date :||October 2013|
Experimental: Salpingectomy group
Participants in this group will have their fallopian tubes removed.
Removal of the fallopian tubes
No Intervention: No Salpingectomy Group
Participants in this group will not have their fallopian tubes removed.
- Change from baseline in ovarian function as measured by Anti-Mullerian Hormone (AMH) [ Time Frame: AMH blood samples collected prior to surgery at day 1 (the day of the surgery) and at 1 and 3 months after day 1. ]
- Patient demographics [ Time Frame: Prior to surgery ]The following routinely collected information will be included in the data analysis: age, body mass index, and surgery indication.
- Patient surgical outcomes [ Time Frame: Postoperatively on day 1 ]The following surgical outcomes will be collected postoperatively: total operating time, estimated blood loss, surgical complications, and surgical pathology.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01578759
|United States, North Carolina|
|Division of Advanced Laparoscopy and Pelvic Pain, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill|
|Chapel Hill, North Carolina, United States, 27599|
|Principal Investigator:||Austin Findley, MD||University of North Carolina, Chapel Hill|